| Arnold JJ, Fyrberg MD, Meezan E, et al.
Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside. [JOURNAL ARTICLE]
J Pharm Sci 2009 Nov 5.
Abstract | Full Citation | Find Related Articles |
| Rollin G, Punales M, Geremia C, et al.
[Use of insulin glargine in type 1 diabetes children with less than eight years old] [English Abstract, Journal Article]
Arq Bras Endocrinol Metabol 2009 Aug; 53(6):721-5.
Abstract | Full Citation |
| Kumari J, Dharmarajan TS
Insulin Glargine Induced Persistent Intractable Hypoglycemia, with Variable Presentations in Older Diabetic Patients: An Experience of 4 Cases. [LETTER]
J Am Med Dir Assoc 2009 Nov; 10(9):672-673.
Full Citation | Find Related Articles |
| Butler PC
Insulin glargine controversy: a tribute to the editorial team at Diabetologia. [Editorial]
Diabetes 2009 Nov; 58(11):2427-8.
Full Citation | Publisher Full Text | Find Related Articles |
| Simon D
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues. [JOURNAL ARTICLE]
Diabetologia 2009 Oct 27.
Full Citation | Find Related Articles |
| Dejgaard A, Lynggaard H, Råstam J, et al.
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis. [JOURNAL ARTICLE]
Diabetologia 2009 Oct 17.
Abstract | Full Citation |
| Yagasaki H, Kobayashi K, Saitou T, et al.
Nocturnal Blood Glucose and IGFBP-1 Changes in Type 1 Diabetes: Differences in the Dawn Phenomenon between Insulin Regimens. [JOURNAL ARTICLE]
Exp Clin Endocrinol Diabetes 2009 Oct 15.
Abstract | Full Citation | Find Related Articles |
| Strojek K, Bebakar WM, Khutsoane DT, et al.
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 12.
Abstract | Full Citation | Find Related Articles |
| Clement FM, Harris A, Li JJ, et al.
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. [Comparative Study, Journal Article, Research Support, Non-U.S. Gov't]
JAMA 2009 Oct 7; 302(13):1437-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Pollex EK, Feig DS, Lubetsky A, et al.
Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study. [JOURNAL ARTICLE]
Diabetes Care 2009 Oct 6.
Abstract | Full Citation |
  |
